+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 0Days - 17Years
All Genders
ID03593408

Studying How Sedative and Pain Medications Behave in Children on ECMO Support

Led by Boston Children's Hospital · Updated on 2026-10-23

20

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying how the blood levels of certain sedative and pain-relieving drugs change in children who are supported with extracorporeal membrane oxygenation ECMO. The drugs being studied include dexmedetomidine, fentanyl, morphine, and midazolam. The goal is to understand how these medicines behave in the body during ECMO support, which is a life-support technique used in critical care. The study observes pediatric patients who are on ECMO and receiving one or more of the four drugs as part of their sedation management under hospital protocols. There is no intervention or treatment assigned by the study instead, researchers measure drug concentrations in the blood at specified times during and after sedation dosing changes. Participants will have blood samples collected at various time points starting from the baseline before drug administration, then at 30, 60, 120 minutes, and at 4, 6, and 12 hours after each change in dosing. Additional samples are taken after stopping the drug at several intervals up to 4 hours. The study monitors these levels throughout sedation management to gather detailed pharmacokinetic data. Participation lasts while the child is under sedation with these drugs during ECMO support.

CONDITIONS

Brief Title

Pharmacokinetics of Sedatives and Analgesics During Extracorporeal Membrane Oxygenation (ECMO) Support

Research Team

V

Viviane Nasr, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here